Gilder Gagnon Howe & CO LLC Delcath Systems, Inc. Transaction History
Gilder Gagnon Howe & CO LLC
- $8.41 Billion
- Q3 2025
A detailed history of Gilder Gagnon Howe & CO LLC transactions in Delcath Systems, Inc. stock. As of the latest transaction made, Gilder Gagnon Howe & CO LLC holds 35,819 shares of DCTH stock, worth $319,863. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,819
Previous 33,133
8.11%
Holding current value
$319,863
Previous $450,000
14.44%
% of portfolio
0.0%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding DCTH
# of Institutions
130Shares Held
13MCall Options Held
133KPut Options Held
159K-
Vanguard Group Inc Valley Forge, PA1.66MShares$14.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA688KShares$6.14 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT666KShares$5.95 Million0.29% of portfolio
-
State Street Corp Boston, MA621KShares$5.55 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA570KShares$5.09 Million0.97% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $76.8M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...